In This Article:
Brussels, September 23, 2024, 6:00pm CEST - Regulated information
In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code of Companies and Associations, Solvay SA hereby discloses certain information in relation to its Share Buyback Program, announced on August 1, 2024.
Solvay has repurchased 24,455 Solvay shares in the period from September 16, 2024 up to and including September 20, 2024, as follows:
Date of repurchase | Number of shares | Average price paid | Max price paid | Min price paid | Total | Market |
16-09-2024 | 12 | 31.1300 | 31.13 | 31.13 | 373.56 | AQEU |
16-09-2024 | 997 | 31.1790 | 31.28 | 31.12 | 31,085.46 | CEUX |
16-09-2024 | 312 | 31.1237 | 31.14 | 31.10 | 9,710.59 | TQEX |
16-09-2024 | 6,834 | 31.2010 | 31.45 | 31.10 | 213,227.63 | XBRU |
17-09-2024 | 500 | 32.3520 | 32.55 | 32.17 | 16,176.00 | CEUX |
18-09-2024 | 500 | 32.8784 | 33.34 | 32.53 | 16,439.20 | XBRU |
19-09-2024 | 25 | 34.4400 | 34.44 | 34.44 | 861 | CEUX |
19-09-2024 | 475 | 34.2954 | 34.50 | 34.08 | 16,290.32 | XBRU |
20-09-2024 | 215 | 34.2752 | 34.35 | 34.20 | 7,369.17 | AQEU |
20-09-2024 | 1,495 | 34.2924 | 34.54 | 34.19 | 51,267.14 | CEUX |
20-09-2024 | 573 | 34.2995 | 34.36 | 34.23 | 19,653.61 | TQEX |
20-09-2024 | 12,517 | 34.3072 | 34.52 | 33.96 | 429,423.22 | XBRU |
As of September 20, 2024, Solvay held a total of 1,371,365 own shares, spread out as follows:
-
1,080,402 Solvay shares held by Solvay SA; and
-
290,963 Solvay shares held by Solvay Stock Option Management SRL (“SSOM”), a wholly owned indirect subsidiary of Solvay SA.
Contacts
Media relations | Investor relations |
Peter Boelaert | Boris Cambon-Lalanne |
Safe harbor
This press release may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this press release is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&I projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements. Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements.